This means a tumor, or lump, has grown in the heart muscle or other heart tissue. These tumors can be cancerous or non-cancerous. They can sometimes block blood flow or cause the heart to beat irregularly, leading to symptoms like shortness of breath or chest pain.
Every report comes from a Lived member, sent anonymously.
Have you had Heart Surgery for Heart Cancer?
Heart cancer is a broad name for tumors that grow in or on the heart. Despite the name, most tumors that start in the heart, roughly three quarters or more, are not cancer. They are benign, meaning they do not spread to other parts of the body. The most common is a myxoma, a soft, jelly-like growth usually attached by a stalk inside the left upper chamber (the left atrium). Only about 10 to 25 percent of tumors that start in the heart are malignant, and most of those are sarcomas, cancers of the heart's muscle, blood vessel or connective tissue. A tumor that starts in the heart is called primary. Far more often, a tumor in the heart is secondary: cancer that has spread there from another organ, such as the lung, breast, skin (melanoma) or the lining around the lungs (mesothelioma). Primary heart tumors of any kind are rare. Even a benign heart tumor can be serious because of where it sits. It can partly block blood moving through a valve, disturb the heart's rhythm, or shed fragments or clots that travel to the brain or elsewhere. Some cause vague, whole-body symptoms such as fever, tiredness and weight loss, and some cause no symptoms and are found by chance on a heart scan.
For most heart tumors, no cause is known, and there is nothing a person did to bring one on. A few inherited conditions raise the risk of specific types. Tuberous sclerosis complex, a genetic condition that causes benign growths in many organs, accounts for most rhabdomyomas, the most common heart tumor in babies and children. Carney complex, an inherited condition that also causes spotty skin pigmentation and hormone problems, accounts for a small share of myxomas, often appearing at a younger age and sometimes as more than one tumor. Gorlin syndrome, another inherited condition, is linked to cardiac fibromas, benign growths within the heart muscle that are seen mainly in children. Secondary heart tumors arise in people who already have cancer elsewhere. Spread to the heart is most likely with mesothelioma, melanoma, and lung and breast cancers, but almost any cancer can reach the heart. Myxomas are most often found in middle age, while papillary fibroelastomas, small growths usually on a heart valve, mostly appear in older adults.
An echocardiogram, an ultrasound of the heart, is usually the first test. It shows the tumor's size, where it is attached, how much it moves and whether it is affecting blood flow. Sometimes the ultrasound probe is passed down the throat (a transesophageal echocardiogram) for a closer view of the upper chambers and valves. Cardiac MRI (magnetic resonance imaging) is the most detailed scan for telling one kind of mass from another. The way the tissue looks and takes up contrast dye helps distinguish a tumor from a blood clot, and a benign growth from one more likely to be cancer. CT (computed tomography) scans and PET (positron emission tomography) scans can show whether a mass has spread or invaded nearby structures, which is especially important when cancer is suspected. An electrocardiogram (ECG) checks for rhythm problems, and blood tests may look for inflammation. Imaging often points strongly toward a diagnosis, but examining the tissue under a microscope, usually after the tumor is removed, confirms what it is. In someone with a known cancer elsewhere, a new heart mass is assessed as possible spread of that cancer.
Treatment depends mainly on whether the tumor is benign or malignant, where it sits and what it is doing. Benign tumors that cause symptoms are usually removed with open-heart surgery. A myxoma or other mobile growth on the left side of the heart is generally removed soon after it is found, even if it is small and causing no symptoms, because pieces can break off and cause a stroke. Complete removal, including the base where the tumor attaches, usually cures a myxoma. A papillary fibroelastoma on a valve is typically removed if it is large, very mobile or has already caused a stroke or blockage, often while repairing rather than replacing the valve. Some benign tumors on the right side of the heart that cause no symptoms can instead be watched with regular echocardiograms, if there is no opening between the heart's chambers that would let a fragment reach the brain. Children are treated differently. Rhabdomyomas often shrink and disappear on their own over time, so many need only monitoring. When one blocks blood flow or causes a dangerous rhythm, surgery or everolimus, a targeted medicine already used for other growths caused by tuberous sclerosis complex, may be used to shrink it, in selected cases rather than as a standard approved treatment for heart tumors. Sarcomas that start in the heart are treated by removing as much of the tumor as safely possible when the cancer has not spread widely, sometimes followed by chemotherapy or radiation. How much these added treatments help is uncertain. Care is usually planned by a team that includes cardiac surgeons, cancer specialists and heart specialists at a center with experience in these rare tumors. When cancer has spread to the heart from elsewhere, treatment focuses on the original cancer, with procedures to relieve symptoms such as draining fluid around the heart when needed.
The outlook varies more than for almost any other heart condition, because the label covers very different diseases. After a myxoma is fully removed, most people recover and return to their usual lives, with long-term results that are generally excellent. Myxomas occasionally come back, more often in people with Carney complex or a family history, so follow-up echocardiograms are recommended, commonly one year after surgery and then every several years, as the care team advises. For children with rhabdomyomas, the heart tumors often matter less over time than the other effects of tuberous sclerosis complex, which needs its own long-term care. Malignant tumors that start in the heart are a much harder diagnosis. They are often found after they have already spread, and survival is usually limited. For sarcomas, in published reports, half of people lived about 6 to 18 months after diagnosis, with angiosarcoma, a sarcoma that arises from blood-vessel cells, generally the most aggressive. Individual outcomes vary, and complete surgical removal is linked with longer survival. Planning with the care team about treatment goals, symptom relief and support is an important part of care. When cancer has spread to the heart from elsewhere, the outlook depends mostly on the original cancer.
See a clinician if you have unexplained shortness of breath, tiredness, dizziness or fainting spells, palpitations, or fever and weight loss without another cause, especially if you have a known cancer or an inherited condition linked to heart tumors. If a heart tumor has been found, contact your care team promptly about breathlessness that is new or worsening (including when lying down), or a racing or irregular heartbeat. Any fainting spell needs evaluation the same day, because it can mean the tumor is briefly blocking a valve or causing a dangerous heart rhythm: contact your care team right away, and if they cannot see you that day, get emergency care. Call 911 right away for severe or sudden trouble breathing, chest pain, or fainting with chest pain or a racing heartbeat, because a tumor can suddenly block blood flow through the heart. Also call 911 for signs of a stroke, such as sudden weakness or numbness on one side, a drooping face, trouble speaking or sudden loss of vision, because fragments from a heart tumor can block blood flow to the brain.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Heart Cancer is like, what's helped you, or ask the community a question.